Brief: Jubilant Pharmova Says Jubilant Biosys Subscribes To 80% Equity Capital In JASMIN
March 20 (Reuters) - Jubilant Pharmova Ltd JUBA.NS: JUBILANT PHARMOVA -JUBILANT BIOSYS SUBSCRIBES TO 80% EQUITY CAPITAL IN JASMIN JUBILANT PHARMOVA - JASMIN ACQUIRES PF'S RESEARCH AND DEVELOPMENT CENTRE AT SAINT JULIEN, FRANCE Source text: ID:nBSELLpWh Further company coverage: JUBA.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jubilant Pharmova
See all newsBrief: Jubilant Pharmova Sept-Quarter Consol Net Profit 312 Million Rupees
Brief: Jubilant Pharmova Says Jubilant Therapeutics Announces Oral Presentation Of Preliminary Phase 1 Clinical Data For JBI-802
India New Issue-Jubilant Pharmova to issue 3-year bonds, bankers say
India's Jubilant Pharmova eyes $150 mln through rupee debt sale, bankers say
Brief: Jubilant Pharmova To Consider Raising Of Funds Through Issuance Of Non- Convertible Debentures